RNA-Targeted Therapeutics in Cardiovascular Risk Reduction: From Gene Silencing to Precision Cardiology
- DOI
- 10.1097/crd.0000000000001533
- Published
- 2026-11-06
- Container
- Cardiology in Review
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/crd.0000000000001533,
title = {RNA-Targeted Therapeutics in Cardiovascular Risk Reduction: From Gene Silencing to Precision Cardiology},
author = {Ali Karim and Sakan Binte Imran and Yusra Muhammad Yousuf and Duaa Asad and Zubia Hassan and Haiqa Rahman and Muskan Aamir and Tuyyab Anwer and Sumhera Fatima and Zain Ali and Farhan Karim and Siddiqa Asad and Mehnaz Ejaz Khokhar and Ziaurrahman Musafer Konar},
year = {2026},
journal = {Cardiology in Review},
doi = {10.1097/crd.0000000000001533},
url = {https://doi.org/10.1097/crd.0000000000001533}
}RIS
TY - JOUR TI - RNA-Targeted Therapeutics in Cardiovascular Risk Reduction: From Gene Silencing to Precision Cardiology AU - Ali Karim AU - Sakan Binte Imran AU - Yusra Muhammad Yousuf AU - Duaa Asad AU - Zubia Hassan AU - Haiqa Rahman AU - Muskan Aamir AU - Tuyyab Anwer AU - Sumhera Fatima AU - Zain Ali AU - Farhan Karim AU - Siddiqa Asad AU - Mehnaz Ejaz Khokhar AU - Ziaurrahman Musafer Konar PY - 2026 JO - Cardiology in Review DO - 10.1097/crd.0000000000001533 UR - https://doi.org/10.1097/crd.0000000000001533 ER -
APA
Karim, A., Imran, S. B., Yousuf, Y. M., Asad, D., Hassan, Z., Rahman, H., Aamir, M., Anwer, T., Fatima, S., Ali, Z., Karim, F., Asad, S., Khokhar, M. E., & Konar, Z. M. (2026). RNA-Targeted Therapeutics in Cardiovascular Risk Reduction: From Gene Silencing to Precision Cardiology. Cardiology in Review. https://doi.org/10.1097/crd.0000000000001533
Source records
- crossref · retrieved 2026-11-07T03:33:40.946Z